Eli Lilly and Company Stock Price and Value Analysis

Eli Lilly and Company (NYSE:LLY) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

  • Ticker: LLY (NYSE)
  • Current price: $1351.12
  • Sector: Unknown
  • Industry: Unknown
  • Dividend yield: 0.48%

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Eli Lilly and Company to reach your target.

Target type

LLY Free Cash Flow Trend

Free Cash Flow trendline for LLY
Free Cash Flow trendline for Eli Lilly and Company
CSV

Based on historical returns, we believe that Eli Lilly and Company can grow its free cash at a rate of about 16%. That's positive!

AdvantagesDisadvantages
  • This company is very stable.
  • This company is making money at a great rate!
  • This company has a low dividend yield.
  • This stock looks overpriced.
  • This company has wild ups and downs.

Inside the LLY Numbers

LLY Price
(Eli Lilly and Company stock price per share)
$1351.12
[?] LLY Fair Price
(based on intrinsic value)
$162.57
[?] LLY Safety Price (based on a variable margin of safety) $130.06
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 165% higher than other Unknown stocks
[?] PE Ratio versus Industry 14% lower than other Unknown stocks
[?] Cash Yield 0.26%
[?] Free Cash Flow Jitter 40%
[?] Dividend Yield 0.48% (tax impact)
Shares Shorted 7,213,927

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 7,213,927 shares shorted. With 888,455,816 shares available for purchase and an average trading volume over the past 10 trading days of 3,081,890, it would take at least 2.3 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2007 59478 5,155
2008 59478 7,296
2009 59478 4,336
2010 59478 6,857
2011 59478 7,235
2012 59478 5,305
2013 59478 5,735
2014 59478 4,458
2015 59478 2,965
2016 59478 4,851
2017 59478 5,616
2018 59478 5,525
2019 59478 4,837
2020 59478 6,500
2021 59478 7,366
2022 59478 7,586
2023 59478 4,240
2024 59478 8,818
2025 59478 16,813

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2007 to 2025 with positive net income, operating cash flow totaled $108,578 million against net income of $99,050 million, or 1.10 times. Net income was negative in 2 of the 19 years, and those years are left out of the ratio.

In 2025, operating cash flow was 0.81 times net income, compared with 1.30 times for the earliest three years (2007 to 2009).

Cash conversion in 2025 was 0.81, at least 0.25 under the 1.30 earliest three-year ratio. Gaps like this come from non-cash gains or from cash tied up in receivables, inventory or other working capital.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2007 2,953 5,155 not reported 1.75
2008 -2,072 7,296 not reported n/a
2009 4,329 4,336 not reported 1.00
2010 5,070 6,857 not reported 1.35
2011 4,348 7,235 not reported 1.66
2012 4,089 5,305 not reported 1.30
2013 4,685 5,735 not reported 1.22
2014 2,391 4,458 not reported 1.87
2015 2,408 2,965 not reported 1.23
2016 2,738 4,851 not reported 1.77
2017 -204 5,616 not reported n/a
2018 3,232 5,525 not reported 1.71
2019 8,318 4,837 not reported 0.58
2020 6,194 6,500 not reported 1.05
2021 5,582 7,366 not reported 1.32
2022 6,245 7,586 not reported 1.21
2023 5,240 4,240 not reported 0.81
2024 10,590 8,818 not reported 0.83
2025 20,640 16,813 not reported 0.81

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $72,150 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $32,515 million, 45.1% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.

In 10 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $20,059 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $9,492 million, 56.5% of estimated free cash flow of $16,813 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 4,851 2,159 600 2,759 56.9%
2017 5,616 2,192 300 2,492 44.4%
2018 5,525 2,312 4,151 6,463 117.0%
2019 4,837 2,410 4,400 6,810 140.8%
2020 6,500 2,687 500 3,187 49.0%
2021 7,366 3,087 1,250 4,337 58.9%
2022 7,586 3,536 1,500 5,036 66.4%
2023 4,240 4,069 750 4,819 113.7%
2024 8,818 4,680 2,500 7,180 81.4%
2025 16,813 5,384 4,108 9,492 56.5%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $18,634 million in 2007 and $65,179 million in 2025, a compound annual growth rate of 7.2% over 18 years.

Revenue rose 44.7% from 2024 to 2025.

Our estimated free cash flow was $16,813 million in 2025, 25.8% of revenue. In 2007 the estimated margin was 27.7%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2007 18,634 5,155 27.7%
2008 20,372 7,296 35.8%
2009 21,836 4,336 19.9%
2010 23,076 6,857 29.7%
2011 24,287 7,235 29.8%
2012 22,603 5,305 23.5%
2013 23,113 5,735 24.8%
2014 19,616 4,458 22.7%
2015 19,959 2,965 14.9%
2016 21,222 4,851 22.9%
2017 19,974 5,616 28.1%
2018 21,493 5,525 25.7%
2019 22,320 4,837 21.7%
2020 24,540 6,500 26.5%
2021 28,318 7,366 26.0%
2022 28,541 7,586 26.6%
2023 34,124 4,240 12.4%
2024 45,043 8,818 19.6%
2025 65,179 16,813 25.8%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $7,268 million against total liabilities of $85,941 million, or 8.5% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 76.4% of total assets in 2025, compared with 76.9% in 2008, a decrease of 0.5 percentage points.

Stockholders equity was $26,535 million in 2025, compared with $2.4 million in 2008, a rise of 1105525.0%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 24.0% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2008 29,213 5,497 22,475 2.4
2009 27,461 4,463 17,936 1.6
2010 31,001 5,993 18,589 12,413
2011 33,660 5,923 20,124 13,536
2012 34,399 4,019 19,625 14,774
2013 35,249 3,830 17,608 17,641
2014 36,308 3,872 20,920 15,388
2015 35,569 3,666 20,979 14,590
2016 38,806 4,582 24,725 14,081
2017 44,981 6,536 33,313 11,668
2018 43,908 7,321 32,999 10,909
2019 39,286 2,338 36,587 2,699
2020 46,633 3,657 40,808 5,825
2021 48,806 3,819 39,651 9,155
2022 49,490 2,067 38,714 10,775
2023 64,006 2,819 53,143 10,864
2024 78,715 3,268 64,443 14,352
2025 112,476 7,268 85,941 26,535

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $1,351.12, our model's value equals that price if free cash flow grows an average of 49.9 percent a year over the 10 projection years. Our model assumes 16.4 percent a year for this stock, so the price implies growth of 49.9 percent, which is above the 16.4 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

At 49.9 percent a year, free cash flow would grow about 57.2 times over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $3,130 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $1,080.90 46.3%
Current price $1,351.12 49.9%
20 percent above the current price $1,621.34 52.8%
Our model (stored fair price) $162.57 16.4%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

At $1351.12, Eli Lilly and Company trades above our fair value estimate of $162.57.

Every one of the 19 fiscal years we have for Eli Lilly and Company under its current filer shows positive free cash flow.

Average free cash flow over the last three years of data was $9,957 million, and across the first three years it was $5,595 million; over the period it rose sharply.

Year-to-year variability in free cash flow is volatile, measured at 40%.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

The dividend yield for Eli Lilly and Company is 0.48%.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 59478.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-19
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: LLY annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in LLY

Does Eli Lilly and Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: LLY

This example shows how we apply the Trendshare checklist to LLY: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 1351.12
    • Market cap: $1.2T
    • EPS: 30.81
  2. Step 2 — Valuation checks

    • P/E: 43.853
    • FCF yield: 0.3%
    • Date checked: Nov 19, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.